Sign in
Taking people in United StatesNo phase

Understanding the Role of Doulas in Supporting People With PMADs

Key facts

Who runs it
University of Montana
Where
Missoula, United StatesSee the site
Trial code
Status
Recruiting
People taking part
75 people, planned
Started
26 Nov 2024
Expected to end
31 Dec 2026
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Standard Doula Care Plus PMAD Intervention
  • Standard Doula Care
Record updated
14 August 2026

Who can take part

Age
18 years and older
Sex
Women only
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Participants must be over the age of 18
  • Currently pregnant and between 13 and 26 gestational weeks at the time of enrollment
  • Live in a HRSA-designated rural area of Montana

Who cannot take part

  • They are under the age of 18
  • Not currently pregnant
  • Not between 13-26 gestational weeks at the time of enrollment
  • If they do not live in a HRSA-designated rural are of Montana

This trial is currently available in United States.

  • University of MontanaMissoula, United StatesContact: Jessica L Liddell, PhDTaking people

About the trial

What the trial wants to find out

Detailed Description The doula-led intervention developed during the first phase of this project will be pilot tested for feasibility. Following the recruitment procedures described in the recruitment and retention plan, approximately 75 participants will be enrolled into the study. Twenty-five of the participants will receive regular doula care and 25 of the participants will receive care from a doula trained in the PMAD doula training throughout their pregnancy, childbirth, and postpartum time period, following the intervention procedures developed in Aim 2 of this study. Twenty-five women will not receive care from a doula and will receive perinatal care as usual. Women in all groups will take surveys via REDCap during their enrollment in the intervention, at 1 month postpartum, 3 months, and 6 months postpartum (at the conclusion of the intervention). All participants who receive the PMAD doula intervention will complete checklists after each session with their doula, to assess fidelity to the intervention. Participant communication with their doula via patient notebook will also be assessed for fidelity to the intervention.

The 3 groups in the trial

  • Standard Doula Care Plus the PMAD InterventionTreatment being tested

    Participants in this arm will receive standard perinatal doula care provided by doulas trained in the DONA International doula training in addition to PMAD-specific care from their doulas.

    Treatment: Standard Doula Care Plus PMAD Intervention

  • Standard Doula CareExisting treatment, for comparison

    Participants in this arm will receive standard perinatal doula care provided by doulas trained in the DONA International doula training.

  • Standard Maternal CareNo study treatment, for comparison

    In this arm participants will receive standard perinatal medical care and will not receive care from a doula.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
14 August 2026